TOCILIZUMAB , SECUKINUMAB , ANAKINRA , ADALIMUMAB , RITUXIMAB, USTEKINUMAB clinical trials

PIMOC - Personalized targeted therapies in inflammatory complex multi organ disease

This study looks at new ways to treat serious, ongoing inflammatory diseases that haven't responded to other treatments. Researchers are testing different existing medicines to see which ones work best to reduce inflammation and improve symptoms in patients with complex conditions.